ProCE Banner Activity

Optimizing Outcomes in Gynecologic Cancers: CCO/Smart Patients Healthcare Equity Program

Clinical Thought
Read this commentary from Eloise Chapman-Davis, MD, FACOG, sharing key takeaways about healthcare equity in endometrial, ovarian, and cervical cancers from a CCO/Smart Patients health equity program.

Released: March 01, 2022

Expiration: February 28, 2023

Share

Faculty

Eloise Chapman-Davis

Eloise Chapman-Davis, MD, FACOG

Associate Professor of Obstetrics and Gynecology
Division Director of Gynecologic Oncology
Associate Director of Diversity Equity Inclusion
Sandra & Edward Meyer Cancer Center
Weill Cornell Medicine
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Partners

Smart Patients

ProCE Banner

Faculty Disclosure

Primary Author

Eloise Chapman-Davis, MD, FACOG

Associate Professor of Obstetrics and Gynecology
Division Director of Gynecologic Oncology
Associate Director of Diversity Equity Inclusion
Sandra & Edward Meyer Cancer Center
Weill Cornell Medicine
New York, New York

Eloise Chapman-Davis, MD, FACOG, has no relevant conflicts of interest to report.